Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2)

British Journal of Pharmacology

Volumn 138, Issue 4, 2003, Pages 564-573

  Anderson, Catriona M H ^a   Mendoza, Maria E ^a   Kennedy, David J ^a   Raldua, Demetrio ^a   Thwaites, David T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Caco 2 cell; Dipeptide transport; Epithelial transport; hPepT1; Human intestine; NHE3; NHERF; PACAP; VIP

Indexed keywords

2',7' BIS(2 CARBOXYETHYL) 5(6) CARBOXYFLUORESCEIN; CARRIER PROTEIN; DIPEPTIDE; FLUORESCEIN DERIVATIVE; GLYCYLSARCOSINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN INHIBITOR; S 1611; SODIUM PROTON EXCHANGE PROTEIN 3; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ACIDIFICATION; APICAL MEMBRANE; ARTICLE; CELL PH; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE CELL; MODULATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM TRANSPORT; WESTERN BLOTTING;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTESTINAL ABSORPTION; INTESTINES; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; SODIUM-HYDROGEN ANTIPORTER; SYMPORTERS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0037293434     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705049     Document Type: Article

References (50)

1. BERLIOZ, F., MAORET, J.J., PARIS, H., LABURTHE, M., FARINOTTI, R. & ROZE, C. (2000). alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line. J. Pharmacol. Exp. Ther., 294, 466-472.
2. BLOOM, S.R., POLAK, J.M. & PEARSE, A.G.E. (1973). Vasoactive intestinal peptide and watery diarrhoea syndrome. Lancet, 2, 14-16.
3. + exchanger isoform, NHE3. Am. J. Physiol., 269, C198-C206.
4. BROWN, D.R. & MILLER, R.J. (1991). Neurohormonal control of fluid and electrolyte transport in intestinal mucosa. In Handbook of Physiology (section 6, Vol 4), eds. Field, M. & Frizzell, R.A. pp. 527-587. Besthesda, MD: American Physiological Society.
5. BUYSE, M., BERLIOZ, F., GUILMEAU, S., TSOCAS, A., VOISIN, T., PERANZI, G., MERLIN, D., LABURTHE, M., LEWIN, M.J.M., ROZE, C. & BADO, A. (2001). PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J. Clin. Invest., 108, 1483-1494.
6. CASSUTO, J., FAHRENKRUG, J., JODAL, M., TUTTLE, R. & LUNDGREN, O. (1981). Release of vasoactive intestinal peptide from the cat small intestine exposed to cholera toxin. Gut, 22, 958-963.
7. COUVINEAU, A., ROUYER-FESSARD, C., DARMOUL, D., MAORET, J.J., CARRERO, I., OGIER-DENIS, E. & LABURTHE, M. (1994). Human intestinal VIP receptor: Cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Comm., 200, 769-776.
8. DANIEL, H., FETT, C. & KRATZ, A. (1989). Demonstration and modification of intervillous pH profiles in rat small intestine in vitro. Am. J. Physiol., 257, G489-G495.
9. DANTZIG, A.H. & BERGIN, L. (1990). Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta, 1027, 211-217.
10. DELIE, F. & RUBAS, W. (1997). A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug, 14, 221-286.
11. DHARMSATHAPHORN, K., HARMS, V., YAMASHIRO, D.J., HUGHES, R.J., BINDER, H.J. & WRIGHT, E.M. (1983). Preferential binding of vasoactive intestinal peptide to the basolateral membrane of rat and rabbit enterocytes. J. Clin. Invest., 71, 27-35.
12. FERRI, G.L., BOTTI, P.L., VEZZADINI, P., BILIOTTI, G., BLOOM, S.R. & POLAK, J.M. (1982). Peptide-containing innervation of the human intestinal mucosa. Histochemistry, 76, 413-420.
13. GANAPATHY, V. & LEIBACH, F.H. (1985). Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol., 249, G289-G294.
14. HARMAR, A.J., ARIMURA, A., GOZES, I., JOURNOT, L., LABURTHE, M., PISEGNA, J.R., RAWLINGS, S.R., ROBBERECHT, P., SAID, S.I., SREEDHARAN, S.P., WANK, S.A. & WASCHEK, J.A. (1998). International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev., 50, 265-270.
15. HOOGERWERF, W.A., TSAO, S.C., DEVUYST, O., LEVINE, S.A., YUN, C.H.C., YIP, J.W., COHEN, M.E., WILSON, P.D., LAZENBY, A.J., TSE, C.M. & DONOWITZ, M. (1996). NHE2 and NHE3 are human and rabbit intestinal brush-border proteins. Am. J. Physiol., 270, G29-G41.
16. HUMPHREY, M.J. & RINGROSE, P.S. (1986). Peptides and related drugs: a review of their absorption, metabolism and excretion. Drug Metab. Rev., 17, 283-310.
17. KREJS, G.J., FORDTRAN, J.S., FAHRENKRUG, J., SCHAFFALITZKY DE MUCKADELL, O.B., FISCHER, J.E., HUMPHREY, C.S., O'DORISIO, T.M., SAID, S.I., WALSH, J.H. & SHULKES A.A. (1980). Effect of VIP infusion on water and ion transport in the human jejunum. Gastroenterology, 78, 722-727.
18. LABURTHE, M., ROUSSET, M., ROUYER-FESSARD, C., COUVINEAU, A., CHANTRET, I., CHEVALIER, G. & ZWEIBAUM, A. (1987). Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. J. Biol. Chem., 262, 10180-10184.
19. +/peptide cotransporter: cloning, functional expression, and chromosomal localization. J. Biol. Chem., 270, 6456-6463.
20. MCEWAN, G.T.A., DANIEL, H., FETT, C., BURGESS, M.N. & LUCAS, M.L. (1988). The effect of Escherichia coli STa enterotoxin and other secretagogues on mucosal surface pH of rat small intestine in vivo. Proc. R. Soc. Lond. B, 234, 219-237.
21. + exchangers NHE2 and NHE3 in intestinal epithelial cell line C2/bbe. Am. J. Physiol., 275, C693-C701.
22. MOURAD, F.H. & NASSAR, C.F. (2000). Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Gut, 47, 382-386.
23. +/peptide cotransporter in the human intestinal cell line Caco-2 by cyclic AMP. Biochem. Biophys. Res. Comm., 218, 461-465.
24. + exchange, is a common interactor for merlin and ERM (MERM) proteins. J. Biol. Chem., 273, 1273-1276.
25. 1 receptor agonist. J. Biol. Chem., 275, 24003-24012.
26. ORLOWSKI, J. (1993). Heterologous expression and functional properties of amiloride high affinity (NHE-1) and low affinity (NHE-3) isoforms of the rat Na/H exchanger. J. Biol. Chem., 268, 16369-16377.
27. RECZEK, D., BERRYMAN, M. & BRETSCHER, A. (1997). Identification of EBP50: a PDZ containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J. Cell Biol., 139, 169-179.
28. SAITO, H. & INUI, K.I. (1993). Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol., 265, G289-G294.
29. SALOMON, R., COUVINEAU, A., ROUYER-FESSARD, C. VOISIN, T., LAVALLEE, D., BLAIS, A., DARMOUL, D. & LABURTHE, M. (1993). Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Am. J. Physiol., 264, E294-E300.
30. SCHWARTZ, C.J., KIMBERG, D.V., SHEERIN, H.E., FIELD, M. & SAID, S.I. (1974). Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. J. Clin. Invest., 54, 536-544.
31. SELLIN, J.H. (1996). The pathophysiology of diarrhea. In Molecular Biology of Membrane Transport Disorders. ed. Schultz, S.G. pp. 541-563. New York: Plenum Press.
32. SUNDLER, F., EKBLAD, E., ABSOOD, A., HAKANSON, R., KOVES, K. & ARIMURA, A. (1992). Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience, 46, 439-454.
33. SVOBODA, M., TASTENOY, M., VAN RAMPELBERGH, J., GOOSSENS, J.F., DE NEEF, P., WAELBROECK, M. & ROBBERECHT, P. (1994). Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem. Biophys. Res. Commun., 205, 1617-1624.
34. TAMAI, I., NAKANISHI, T., NAKAHARA, H., SAI, Y., GANAPATHY, V., LEIBACH, F.H. & TSUJI, A. (1998). Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1. J. Pharm. Sci., 87, 1542-1546.
35. +-coupled carriers at both apical and basal membranes. J. Biol. Chem., 268, 7640-7642.
36. THWAITES, D.T., CAVET, M., HIRST, B.H. & SIMMONS, N.L. (1995). Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol., 114, 981-986.
37. + exchange in human intestinal epithelial cells. J. Clin. Invest., 104, 629-635.
38. + symport in intact human intestinal (Caco-2) epithelium: a novel method utilising continuous intracellular pH measurement. Biochem. Biophys. Res. Comm., 194, 432-438.
39. +-coupled absorption. Br. J. Pharmacol., 113, 1050-1056.
40. + exchanger. Gastroenterology, 122, 1322-1333.
41. VAUDRY, D., GONZALEZ, B.J., BASILLE, M., YON, L., FOURNIER, A. & VAUDRY, H. (2000). Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev., 52, 269-324.
42. VOISIN, T., ROUYER-FESSARD, C. & LABURTHE, M. (1990). Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis. Am. J. Physiol., 258, G753-G759.
43. WALKER, D., THWAITES, D.T., SIMMONS, N.L., GILBERT, H.J. & HIRST, B.H. (1998). Substrate upregulation of the human small intestinal peptide transporter, hPepT1. J. Physiol., 507, 697-706.
44. + exchanger from Caco-2 cells, a human intestinal cell line. Am. J. Physiol., 261, G229-G238.
45. WEINMAN, E.J., MINKOFF, C. & SHENOLIKAR, S. (2000). Signal complex regulation of renal transport proteins: NHERF and regulation of NHE3 by PKA. Am. J. Physiol., 279, F393-F399.
46. WENZEL, U., THWAITES, D.T. & DANIEL, H. (1995). Stereoselective uptake of β-lactam antibiotics by the intesinal peptide transporter. Br. J. Pharmacol., 116, 3021-3027.
47. + exchanger. Clin. Pharmacol. Ther., 57, 257-264.
48. +-sensitive medullary neurones. Pflügers Arch., 438, 255-262.
49. YANG, C.Y., DANTZIG, A.H. & PIDGEON, C. (1999). Intestinal peptide transport systems and oral drug availability. Pharm. Res., 16, 1331-1343.
50. + exchanger, NHE3, requires an associated regulatory protein. Proc. Natl. Acad. Sci. U.S.A., 94, 3010-3015.